These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26559322)

  • 1. Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease.
    Hayashi H; Mitsui C; Nakatani E; Fukutomi Y; Kajiwara K; Watai K; Sekiya K; Tsuburai T; Akiyama K; Hasegawa Y; Taniguchi M
    J Allergy Clin Immunol; 2016 May; 137(5):1585-1587.e4. PubMed ID: 26559322
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
    Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
    [No Abstract]   [Full Text] [Related]  

  • 3. Omalizumab can inhibit respiratory reaction during aspirin desensitization.
    Lang DM; Aronica MA; Maierson ES; Wang XF; Vasas DC; Hazen SL
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):98-104. PubMed ID: 29777744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers.
    Higashi N; Mita H; Ono E; Fukutomi Y; Yamaguchi H; Kajiwara K; Tanimoto H; Sekiya K; Akiyama K; Taniguchi M
    J Allergy Clin Immunol; 2010 May; 125(5):1084-1091.e6. PubMed ID: 20304469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
    Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
    Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12½-year journey of a patient with Samter triad syndrome and sporadic omalizumab use.
    Ardusso LR; Neffen H
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):454-6. PubMed ID: 26392046
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase in salivary cysteinyl-leukotriene concentration in patients with aspirin-intolerant asthma.
    Ono E; Taniguchi M; Higashi N; Mita H; Yamaguchi H; Tatsuno S; Fukutomi Y; Tanimoto H; Sekiya K; Oshikata C; Tsuburai T; Tsurikisawa N; Otomo M; Maeda Y; Hasegawa M; Miyazaki E; Kumamoto T; Akiyama K
    Allergol Int; 2011 Mar; 60(1):37-43. PubMed ID: 21099251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab in the treatment of aspirin-exacerbated respiratory disease.
    Bergmann KC; Zuberbier T; Church MK
    J Allergy Clin Immunol Pract; 2015; 3(3):459-60. PubMed ID: 25648572
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.
    Cameli P; D'Alessandro M; Bergantini L; Silvestri E; Romaldi A; Emmi G; Parronchi P; Bargagli E
    Monaldi Arch Chest Dis; 2020 Aug; 90(3):. PubMed ID: 32885934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab treatment in Samter's triad: case series and review of the literature.
    Cameli P; Perruzza M; Salvini M; Fui A; Cekorja B; Refini RM; Sestini P; Bargagli E
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8124-8129. PubMed ID: 31599440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease.
    Aksu K; Kurt E
    Allergol Immunopathol (Madr); 2013; 41(3):208-10. PubMed ID: 22763305
    [No Abstract]   [Full Text] [Related]  

  • 12. Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
    Misso NL; Aggarwal S; Thompson PJ; Vally H
    Int Arch Allergy Immunol; 2009; 149(2):127-32. PubMed ID: 19127069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab.
    Phillips-Angles E; Barranco P; Lluch-Bernal M; Dominguez-Ortega J; López-Carrasco V; Quirce S
    J Allergy Clin Immunol Pract; 2017; 5(3):842-845. PubMed ID: 28117272
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.
    Gaber F; Daham K; Higashi A; Higashi N; Gülich A; Delin I; James A; Skedinger M; Gyllfors P; Nord M; Dahlén SE; Kumlin M; Dahlén B
    Thorax; 2008 Dec; 63(12):1076-82. PubMed ID: 18757457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.
    Cahill KN; Cui J; Kothari P; Murphy K; Raby BA; Singer J; Israel E; Boyce JA; Laidlaw TM
    Am J Respir Crit Care Med; 2019 Sep; 200(6):704-711. PubMed ID: 30978291
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Zileuton Treatment on Sinonasal Quality of Life in Patients with Aspirin-Exacerbated Respiratory Disease.
    Lee SE; Farquhar DR; Adams KN; Masood MM; Senior BA; Thorp BD; Zanation AM; Ebert CS
    Am J Rhinol Allergy; 2019 Nov; 33(6):791-795. PubMed ID: 31483687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
    Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.
    Jean T; Eng V; Sheikh J; Kaplan MS; Goldberg B; Jau Yang S; Samant S
    Allergy Asthma Proc; 2019 Sep; 40(5):316-320. PubMed ID: 31514790
    [No Abstract]   [Full Text] [Related]  

  • 19. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and urinary leukotriene E4 and 9α,11β-prostaglandin F2 release after exercise challenge.
    Baek HS; Choi JH; Oh JW; Lee HB
    Ann Allergy Asthma Immunol; 2013 Aug; 111(2):112-7. PubMed ID: 23886229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.